Discover
YMAB
Y-mAbs Therapeutics, Inc.
8.61
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | ||
| 1y |
8.61
day range
8.61
6.48
52 week range
20.90
| Open | 8.59 | Prev Close | 8.61 | Low | 8.61 | High | 8.61 | Mkt Cap | 363.24M |
| Vol | 709.42K | Avg Vol | 249.12K | EPS | -0.54 | P/E | N/A | Forward P/E | -13.98 |
| Beta | 0.67 | Short Ratio | 13.91 | Inst. Own | 72.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 12.41 | 200-d Avg | 13.15 | 1yr Est | 20.64 |
| Income Statement | |||
| Total Revenue | 19.52M | ||
| Revenues (USD) | 19.52M | ||
| Cost of Revenue | 2.71M | ||
| Gross Profit | 16.81M | ||
| Operating Expenses | 22.42M | ||
| Research and Development Expense | 11.10M | ||
| Selling, General and Administrative Expense | 11.31M | ||
| Operating Income | -5.60M | ||
| Interest Expense | -2.37M | ||
| Income Tax Expense | 7.00K | ||
| Net Income | -3.24M | ||
| Net Income Common Stock | -3.24M | ||
| Net Income Common Stock (USD) | -3.24M | ||
| Consolidated Income | -3.24M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -5.60M | ||
| Earning Before Interest & Taxes (USD) | -5.60M | ||
| Weighted Average Shares | 45.32M | ||
| Weighted Average Shares Diluted | 45.32M | ||
| Balance Sheet | |||
| Cash and Equivalents | 62.29M | ||
| Cash and Equivalents (USD) | 62.29M | ||
| Trade and Non-Trade Receivables | 15.74M | ||
| Current Assets | 91.79M | ||
| Property, Plant & Equipment Net | 3.38M | ||
| Total Assets | 117.21M | ||
| Debt Current | 486.00K | ||
| Total Debt | 3.12M | ||
| Current Liabilities | 22.95M | ||
| Debt Non-Current | 2.64M | ||
| Total Liabilities | 29.72M | ||
| Accumulated Retained Earnings (Deficit) | -495.57M | ||
| Accumulated Other Comprehensive Income | -612.00K | ||
| Shareholders Equity | 87.49M | ||
| Shareholders Equity (USD) | 87.49M | ||
| Assets Non-Current | 25.42M | ||
| Total Debt (USD) | 3.12M | ||
| Goodwill and Intangible Assets | 2.18M | ||
| Inventory | 28.94M | ||
| Liabilities Non-Current | 6.77M | ||
| Trade and Non-Trade Payables | 7.57M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 53.00K | ||
| Net Cash Flow from Financing | 332.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.98M | ||
| Issuance (Purchase) of Equity Shares | 332.00K | ||
| Net Cash Flow from Operations | 1.65M | ||
| Share Based Compensation | 2.90M | ||